furosemide has been researched along with pamidronate in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Spitz, AF | 1 |
| Rosenmund, A | 1 |
| Hara, N; Nakanishi, Y; Takayama, K | 1 |
| Akiba, T; Tanabe, K; Tokumoto, T; Toma, H | 1 |
| Antonakis, PT; Bramis, I; Kafiri, G; Lagoudianakis, E; Manouras, A; Markogiannakis, H; Papadima, A; Toutouzas, KG | 1 |
| Hintzke, C; Ileana, S; Labossiere, R | 1 |
| Hoi, WH; Lee, HY; Leow, MK; Mmed, TA; Sule, A; Tay, JC | 1 |
| Drake, WM; Hanson, PL; Jones, P; Pittaway, JF; Srirangalingam, U | 1 |
| Hopkins-Braddock, P; Liao, M; Magcalas, P | 1 |
| Bacchetta, J; Bordet, F; Dijoud, F; Duncan, A; Mure, PY; Pracros, JP; Tanné, C | 1 |
4 review(s) available for furosemide and pamidronate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Hypercalcemia as an emergency].
Topics: Calcitonin; Calcium; Diphosphonates; Emergencies; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism; Neoplasms; Pamidronate | 1993 |
[Paraneoplastic syndrome].
Topics: Alendronate; Anticoagulants; Cushing Syndrome; Diagnosis, Differential; Diphosphonates; Disseminated Intravascular Coagulation; Diuretics; Furosemide; Heparin; Humans; Hypercalcemia; Inappropriate ADH Syndrome; Lung Neoplasms; Pamidronate; Paraneoplastic Syndromes | 1997 |
[Treatment of bone disease in chronic kidney disease and in renal transplant recipients under K/DOQI clinical practice guidelines].
Topics: Bone Density; Bone Diseases, Metabolic; Calcitonin; Chronic Disease; Diphosphonates; Epoxy Compounds; Furosemide; Humans; Hyperparathyroidism, Secondary; Ion Exchange Resins; Kidney Diseases; Kidney Transplantation; Pamidronate; Parathyroidectomy; Phosphorus; Phosphorus, Dietary; Polyamines; Polyethylenes; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Testosterone; United States; Vitamin D; Vitamin D Deficiency | 2004 |
14 other study(ies) available for furosemide and pamidronate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Management of a functioning mediastinal parathyroid cyst.
Topics: Aged; Bone Density; Calcium; Diphosphonates; Diuretics; Female; Furosemide; Humans; Mediastinal Cyst; Pamidronate; Parathyroid Diseases; Tomography, X-Ray Computed | 1995 |
Intracystic hemorrhage in a mediastinal cystic adenoma causing parathyrotoxic crisis.
Topics: Adenoma; Adult; Bone Density Conservation Agents; Cystadenoma; Diphosphonates; Diuretics; Fluid Therapy; Furosemide; Hemorrhage; Humans; Hypercalcemia; Hyperparathyroidism; Male; Mediastinal Neoplasms; Pamidronate; Parathyroid Neoplasms; Thyroid Crisis; Thyroidectomy | 2008 |
Hypercalcemia of immobilization.
Topics: Bone Density Conservation Agents; Diphosphonates; Diuretics; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Immobilization; Male; Middle Aged; Pamidronate | 2009 |
Hyperparathyroidism due to eutopic PTH secretion from an ectopic intrathymic parathyroid cyst.
Topics: Biomarkers; Biopsy; Calcitonin; Calcium; Choristoma; Diphosphonates; Diuretics; Female; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism; Infusions, Intravenous; Mediastinal Cyst; Middle Aged; Pamidronate; Parathyroid Glands; Parathyroid Hormone; Sodium Chloride; Thoracic Surgery, Video-Assisted; Thyroidectomy; Tomography, X-Ray Computed; Treatment Outcome; Up-Regulation | 2011 |
Renal replacement therapy as a treatment for severe refractory hypercalcemia.
Topics: Adenoma; Adult; Carcinoma; Cinacalcet; Diphosphonates; Drug Resistance; Emergencies; Female; Furosemide; Hemodiafiltration; Hemofiltration; Humans; Hydroxycholecalciferols; Hypercalcemia; Hypoparathyroidism; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Naphthalenes; Pamidronate; Pancreatitis, Acute Necrotizing; Parathyroid Neoplasms; Parathyroidectomy | 2014 |
Case 4: How Much Is Too Much? A Case of Hypercalcemia in a 6-year-old Boy.
Topics: Bone Density Conservation Agents; Calcitonin; Child; Diagnosis, Differential; Dietary Supplements; Diphosphonates; Drug Therapy, Combination; Edema; Exanthema; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Leg; Male; Pain; Pamidronate; Vitamin A | 2015 |
Severe neonatal hypercalcemia revealing congenital mesoblastic nephroma: A case report and management of neonatal hypercalcemia: Severe neonatal hypercalcemia revealing congenital mesoblastic nephroma.
Topics: Calcium; Female; Food, Fortified; Furosemide; Humans; Hypercalcemia; Hypertension; Infant Formula; Infant, Newborn; Kidney Neoplasms; Nephrectomy; Nephroma, Mesoblastic; Pamidronate; Treatment Outcome | 2022 |